FDA
-
-
-
-
-
-
-
Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma
-
-
-
-
-
-
-
Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
-
-
-
-
-
-
-
Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement
-
-
-
-
-
-
-
Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million
-
-
-
-
-
-
-
Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion
-
-
-
-
-
-
-
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare
-
-
-
-
-
-
-
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
-
328,348 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

